← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2006Last known activity
Dec 28, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT06875791Lead sponsorPhase 1/Phase 2Dec 28, 2025
- NCT06875791Sponsor investigatorPhase 1/Phase 2Dec 28, 2025
- NCT04627467Overall official - principal investigatorPhase 2Mar 28, 2020
- NCT04627467Lead sponsorPhase 2Mar 28, 2020
- NCT03136458Lead sponsorN/AJan 1, 2016
- NCT03136458Sponsor investigatorN/AJan 1, 2016
- NCT02542241Lead sponsorPhase 4Dec 1, 2015
- NCT02542241Reponsible party - principal investigatorPhase 4Dec 1, 2015
- NCT02542241Overall official - principal investigatorPhase 4Dec 1, 2015
- NCT03132519Lead sponsorPhase 4Oct 1, 2013
- NCT03132519Overall official - principal investigatorPhase 4Oct 1, 2013
- NCT03132519Reponsible party - principal investigatorPhase 4Oct 1, 2013
- NCT03132519Study chairPhase 4Oct 1, 2013
- NCT01881087Lead sponsorPhase 4Jun 1, 2006
- NCT01881087Overall official - principal investigatorPhase 4Jun 1, 2006
Details
- Last known activity
- Dec 28, 2025